- $5.65bn
- $5.97bn
- $2.36bn
- 84
- 46
- 25
- 50
C2019 December 28th | 2020 December 26th | 2022 December 31st | 2022 January 1st | 2023 December 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,504 | 1,446 | 2,514 | 2,080 | 2,363 |
Cost of Revenue | |||||
Gross Profit | 546 | 501 | 1,007 | 772 | 900 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,311 | 1,283 | 2,014 | 1,695 | 2,002 |
Operating Profit | 193 | 162 | 500 | 385 | 361 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 166 | 161 | 443 | 341 | 329 |
Provision for Income Taxes | |||||
Net Income After Taxes | 139 | 130 | 373 | 284 | 259 |
Net Income Before Extraordinary Items | |||||
Net Income | 139 | 130 | 373 | 284 | 259 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 139 | 130 | 373 | 284 | 259 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.59 | 6.8 | 16.4 | 11.5 | 11.2 |
Dividends per Share |